IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
종목 코드 IRIX
회사 이름IRIDEX Corp
상장일Feb 16, 1996
CEOMr. Patrick Mercer
직원 수93
유형Ordinary Share
회계 연도 종료Feb 16
주소1212 Terra Bella Ave
도시MOUNTAIN VIEW
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호94043
전화16509404700
웹사이트https://www.iridex.com/
종목 코드 IRIX
상장일Feb 16, 1996
CEOMr. Patrick Mercer
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음